Efficacy in Reducing Fractures and Safety of Zoledronic Acid in Men With Osteoporosis

Clinical trial NCT00439647 · COMPLETED

Trial details

NCT number: NCT00439647
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Male Osteoporosis

Start date: 2006-12-01
Primary completion: 2010-10-01
Enrollment: 1199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.